Overview

We’ll explore the overlooked benefits of initiating oncology clinical trials with healthy volunteers rather than patients. The webinar will shed light on the possibilities of organizing oncology trials with healthy volunteers in the early stages, preceding later patient trials.

Objective

Learn how a more nuanced consideration of healthy-volunteer participation in the initial stages of oncology trials can promote innovation and efficiency in the drug development process:

• Gain a unique perspective on the early stages of oncology trials with healthy volunteers.
• Explore the advantages and potential challenges associated with this unconventional approach.
• Acquire practical insights derived from our clinical pharmacology unit's successful execution of healthy-volunteer oncology trials.

 

Agenda

• Introduction to healthy volunteer oncology trials
• Pros and cons of the approach
• Ethical considerations
• Takeaways from oncology studies performed at our own clinical pharmacology unit
• Q&A session: Engage with experts, clarify your concerns.

Target Audience: The webinar is aimed at all pharmaceutical and biotech professionals, clinical pharmacologists, and oncologists and medical professionals specializing in oncology research.

Language: English

Can't make a live session? Register now and receive a complimentary recording after the live event. For further information, please contact: clinicalresearch@sgs.com

_1737907276025